InnoCare (诺诚健华) Pre-IPO: Thoughts on Valuation
InnoCare Pharma Limited is a clinical-stage biopharmaceutical company with a focus on small molecule inhibitors for BTK, and FGFRs. The company...
483 Views
Ascentage Pharma (亚盛医药) IPO: Some Issues with Banker Forecasts
Ascentage Pharma is pre-marketing the USD 200 - 300 million IPO to list in Hong Kong. In our previous insight, we highlight the company's key...
641 Views
Greater Bay Area Initiative - Viablity & Investor Implications, Part II
Last week in Part I we discussed what the GBA Initiative is. The importance of the GBA Initiative cannot be overstated. It is critical to the...
495 Views
Greater Bay Initiative - Upping Integration, Part 1
The US-China trade tensions have eased for the moment. But China’s leaders realise that the real war between a rising and an existing economic...
391 Views
Ascentage Pharma (亚盛医药) IPO: Thoughts on Valuation
Ascentage Pharma is pre-marketing the USD 200 - 300 million IPO to list in Hong Kong. In our previous insight, we highlight the company's key...
468 Views